METHYL 2-((16.BETA.)-2'-METHYL-3,11-DIOXO-5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOL-20-YLIDENE)HYDRAZINECARBOXYLATE
UNII U6UX7A4DF4
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 2-((16.beta.)-2'-methyl-3,11-dioxo-5'h-pregna-1,4-dieno(17,16-d)oxazol-20-ylidene)hydrazinecarboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U6UX7A4DF4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1424921-01-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 2-((16.beta.)-2'-methyl-3,11-dioxo-5'h-pregna-1,4-dieno(17,16-d)oxazol-20-ylidene)hydrazinecarboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.